TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biocell AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
27,846 |
| Financial expenses |
1
|
1,340
|
1 |
| Earnings before taxes |
71
|
797
|
7,643 |
| EBITDA |
-481
|
-443
|
3,629 |
| Total assets |
9,654
|
10,404
|
11,795 |
| Current assets |
5,440
|
7,238
|
8,383 |
| Current liabilities |
1,300
|
1,981
|
3,198 |
| Equity capital |
8,354
|
8,423
|
8,597 |
| - share capital |
672
|
668
|
727 |
| Employees (average) |
0
|
0
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
86.5%
|
81.0%
|
72.9% |
| Turnover per employee | 27,846 | ||
| Profit as a percentage of turnover | 27.4% | ||
| Return on assets (ROA) |
0.7%
|
20.5%
|
64.8% |
| Current ratio |
418.5%
|
365.4%
|
262.1% |
| Return on equity (ROE) |
0.8%
|
9.5%
|
88.9% |
| Change turnover |
0
|
-25,591
|
1,787 |
| Change turnover % |
-100%
|
7% | |
| Chg. No. of employees |
0
|
-1
|
1 |
| Chg. No. of employees % | -100% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.